The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response to single-agent (SA) chemotherapy (CTx) after immunotherapy exposure in non-small cell lung cancer (NSCLC).
 
Gustavo Schvartsman
No Relationships to Disclose
 
S. Andrew Peng
No Relationships to Disclose
 
Giorgios Bis
No Relationships to Disclose
 
J. Jack Lee
No Relationships to Disclose
 
Marcelo Felipe Kuperman Benveniste
No Relationships to Disclose
 
Jianjun Zhang
No Relationships to Disclose
 
Waree Rinsurongkawong
No Relationships to Disclose
 
Jeff Lewis
No Relationships to Disclose
 
Emily Roarty
No Relationships to Disclose
 
Lara Lacerda
No Relationships to Disclose
 
Jack A. Roth
No Relationships to Disclose
 
Stephen Swisher
No Relationships to Disclose
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
Frank V. Fossella
No Relationships to Disclose
 
William Nassib William
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Speakers' Bureau - Boehringer Ingelheim
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); OSI Pharmaceuticals (Inst)